[Parkinsonian tremor and the action of harmaline: experimental facts and hypothetical mechanisms].
Lamarre
Y
Y
Centre de Recherche en Sciences Neurologiques, Département de Physiologie, Université de Montréal, Québec.
Dumont
M
M
Joffroy
A J
AJ
D000818:Animals; D000697:Central Nervous System Stimulants / Q000633:toxicity*; D002531:Cerebellum / Q000187:drug effects / Q000503:physiopathology; D004027:Diencephalon / Q000187:drug effects / Q000503:physiopathology; D004525:Efferent Pathways / Q000187:drug effects / Q000503:physiopathology; D000882:Haplorhini; D006246:Harmaline / Q000633:toxicity*; D008959:Models, Neurological; D009044:Motor Cortex / Q000187:drug effects / Q000503:physiopathology; D009046:Motor Neurons / Q000502:physiology; D009847:Olivary Nucleus / Q000187:drug effects / Q000503:physiopathology; D020734:Parkinsonian Disorders / Q000139:chemically induced / Q000503:physiopathology*; D010507:Periodicity; D011712:Pyramidal Tracts / Q000187:drug effects / Q000503:physiopathology; D014202:Tremor / Q000139:chemically induced* / Q000503:physiopathology; D020651:Ventral Thalamic Nuclei / Q000187:drug effects / Q000503:physiopathology
D000697:Central Nervous System Stimulants; D006246:Harmaline
Le tremblement de type parkinsonien et l'action de l'harmaline: faits expérimentaux et mécanismes hypothétiques.